| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| CMC(元) | 1,389,706,924.83 | 2,988,773,210.09 | - | 2,711,038,744.58 | 1,251,316,495.37 |
| 大分子和细胞与基因治疗服务(元) | 211,476,697.22 | 407,518,945.43 | 211,210,409.44 | 424,936,749.49 | 200,217,167.11 |
| 临床研究服务(元) | 939,326,620.21 | 1,826,208,312.35 | 843,269,367.02 | 1,737,292,625.38 | 805,193,323.86 |
| 实验室服务(元) | 3,892,461,316.76 | 7,046,874,518.81 | 3,371,176,816.35 | 6,660,117,053.80 | 3,380,371,932.59 |
| 化学和制剂工艺开发及生产(元) | - | - | 1,175,747,332.83 | - | - |
| 营业成本(元) | |||||
| CMC(元) | 965,827,677.46 | 1,984,068,508.56 | - | 1,797,947,320.10 | 845,159,408.15 |
| 大分子和细胞与基因治疗服务(元) | 327,167,475.04 | 611,581,976.13 | 277,410,915.35 | 460,202,862.51 | 216,918,186.36 |
| 临床研究服务(元) | 823,559,155.64 | 1,592,025,240.46 | 737,427,319.21 | 1,441,044,132.50 | 668,460,262.80 |
| 实验室服务(元) | 2,132,974,433.48 | 3,881,177,854.47 | 1,872,495,689.01 | 3,710,763,740.52 | 1,857,501,744.70 |
| 化学和制剂工艺开发及生产(元) | - | - | 843,026,164.32 | - | - |
| 毛利(元) | |||||
| CMC(元) | 423,879,247.37 | 1,004,704,701.53 | - | 913,091,424.48 | 406,157,087.22 |
| 大分子和细胞与基因治疗服务(元) | -115,690,777.82 | -204,063,030.70 | -66,200,505.91 | -35,266,113.02 | -16,701,019.25 |
| 临床研究服务(元) | 115,767,464.57 | 234,183,071.89 | 105,842,047.81 | 296,248,492.88 | 136,733,061.06 |
| 实验室服务(元) | 1,759,486,883.28 | 3,165,696,664.34 | 1,498,681,127.34 | 2,949,353,313.28 | 1,522,870,187.89 |
| 化学和制剂工艺开发及生产(元) | - | - | 332,721,168.51 | - | - |
| 毛利率(%) | |||||
| CMC(%) | 30.50 | 33.62 | - | 33.68 | 32.46 |
| 大分子和细胞与基因治疗服务(%) | -54.71 | -50.07 | -31.34 | -8.30 | -8.34 |
| 临床研究服务(%) | 12.32 | 12.82 | 12.55 | 17.05 | 16.98 |
| 实验室服务(%) | 45.20 | 44.92 | 44.46 | 44.28 | 45.05 |
| 化学和制剂工艺开发及生产(%) | - | - | 28.30 | - | - |
| 收入构成(%) | |||||
| CMC(%) | 21.60 | 24.36 | - | 23.51 | 22.20 |
| 大分子和细胞与基因治疗服务(%) | 3.29 | 3.32 | 3.77 | 3.68 | 3.55 |
| 临床研究服务(%) | 14.60 | 14.88 | 15.05 | 15.06 | 14.28 |
| 实验室服务(%) | 60.51 | 57.43 | 60.18 | 57.75 | 59.97 |
| 化学和制剂工艺开发及生产(%) | - | - | 20.99 | - | - |
| 毛利构成(%) | |||||
| CMC(%) | 19.41 | 23.92 | - | 22.14 | 19.82 |
| 大分子和细胞与基因治疗服务(%) | -5.30 | -4.86 | -3.54 | -0.86 | -0.82 |
| 临床研究服务(%) | 5.30 | 5.58 | 5.66 | 7.18 | 6.67 |
| 实验室服务(%) | 80.58 | 75.36 | 80.10 | 71.53 | 74.32 |
| 化学和制剂工艺开发及生产(%) | - | - | 17.78 | - | - |